How Long After Medroxyprogesterone Does Period Start?

Most women who take a course of oral medroxyprogesterone acetate (MPA) can expect withdrawal bleeding to begin within about two to seven days after the last pill, though the window can stretch to fourteen days in some cases. The timing depends on several factors, especially how thick the uterine lining has grown before the medication is stopped. That detail turns out to be far more predictive than the calendar, and understanding why can save you unnecessary worry if your period seems late, or help explain why it never arrives at all.

Why Stopping the Medication Triggers Bleeding

MPA is a synthetic progestin, meaning it mimics what your body’s own progesterone does during the second half of a natural menstrual cycle. In a typical cycle without pregnancy, the ovary’s corpus luteum produces progesterone to stabilize the uterine lining. When that progesterone drops, the lining loses its hormonal support. The withdrawal sets off a cascade: tissue-breakdown enzymes ramp up, inflammatory signals increase, and the blood vessels supplying the lining constrict and then break down, resulting in the controlled shedding you experience as a period.¹

When you take MPA for a set number of days and then stop, you are recreating that same hormonal drop artificially. The drug holds the lining in place while you’re taking it; once you stop, the lining no longer has progestin support and begins to shed. This is why doctors sometimes call it “withdrawal bleeding” rather than a true menstrual period, even though it looks and feels essentially the same.

The Standard Dosing Schedule

The most commonly prescribed regimen for cycle regulation is 10 mg of MPA taken by mouth once daily for 10 to 14 days. This is the protocol used to induce a withdrawal bleed in women with irregular or absent periods, to “reset” the cycle in anovulatory bleeding, and as the standard progestin challenge test used diagnostically. Some clinicians prescribe the medication for 12 days rather than 10, and others may adjust the dose to 5 mg depending on the clinical situation, but 10 mg for 10 days is the most widely cited starting point.

Within that standard course, the timing of your bleed after the last tablet is fairly consistent. Most women see spotting or flow begin somewhere between day two and day seven after their final dose. Some women start bleeding a day or two before they’ve even finished the course, particularly if their endometrium is already thick and unstable. Others won’t see anything for up to two weeks. If fourteen days pass without any bleeding at all, that itself is clinically meaningful information, which we’ll get to below.

Endometrial Thickness Predicts Bleeding Better Than the Calendar

If you’re wondering why your friend bled on day three and you’re still waiting on day ten, the most likely explanation has nothing to do with how fast you metabolize the drug. It has to do with how much lining your uterus built up before you took the medication. A study that measured endometrial thickness by ultrasound before a progestin challenge found that women who bled had an average lining of about 10 mm, while those who did not bleed averaged only 5 mm. An endometrial thickness of 6 mm or more predicted whether withdrawal bleeding would occur with roughly 95% accuracy, and it outperformed blood estrogen levels as a predictor.²

The logic behind this is straightforward. Estrogen is the hormone responsible for building the uterine lining in the first half of the cycle. If your body has been producing enough estrogen to grow a substantial lining, there is material to shed when progesterone is withdrawn. If estrogen levels have been low and the lining is thin, there’s simply not enough tissue to produce noticeable bleeding, no matter how much MPA you take. This is why the same prescription can produce a heavy period in one woman and nothing at all in another.

What the Progestin Challenge Test Actually Tells Your Doctor

Doctors sometimes prescribe a short course of MPA not to treat anything but purely as a diagnostic tool. The logic is simple: give progesterone, take it away, and see what happens. If you bleed, it tells the clinician that your body has enough circulating estrogen to build a lining, and that your uterus and outflow tract are structurally intact. The problem in that case is likely anovulation, meaning your ovaries aren’t releasing eggs on schedule, which prevents the natural progesterone rise and fall that would trigger a period on its own.

If you don’t bleed, the picture is different. The absence of withdrawal bleeding suggests either very low estrogen levels (so no lining was built in the first place), or a structural problem like scarring inside the uterus. Research on this test found that whether or not a woman bleeds after a progestin challenge correlates closely with the volume, structure, and hormone-producing function of her ovaries.³ A positive result (bleeding occurred) and a negative result (no bleeding) point the workup in very different directions, so this simple test can save you from a more invasive evaluation upfront.

One caveat: the progestin challenge is not foolproof. Some women with adequate estrogen still don’t bleed, and some with low estrogen do. The ultrasound measurement of lining thickness, as noted earlier, tends to be a sharper predictor.² Clinicians increasingly combine the challenge with imaging rather than relying on the challenge alone.

How Body Weight Affects the Bleeding Response

Body weight interacts with hormonal bleeding in ways that can seem counterintuitive. You might expect that higher body weight, which is associated with higher estrogen levels due to conversion of androgens in fat tissue, would lead to heavier or more predictable withdrawal bleeding. For oral MPA courses used to induce a period, that general expectation roughly holds: more estrogen means more lining, which means a more robust bleed.

But the picture flips with injectable medroxyprogesterone, the depot shot (DMPA) used for contraception. Research looking at bleeding patterns on DMPA found that women who were overweight or obese actually had a decreased risk of excessive or prolonged bleeding while on the injection, with about half the risk compared to normal-weight women.⁴ The reasons aren’t entirely clear, but one theory is that the higher sustained progestin levels from the depot formulation, combined with the hormonal environment in overweight individuals, more effectively suppress the lining over time.

This distinction matters because people often confuse oral MPA (taken for a set number of days to bring on a period) with the depot injection (given once every three months to prevent pregnancy). The two formulations have very different effects on bleeding patterns, and body weight influences each one differently.

When MPA Is Prescribed for Heavy or Irregular Periods

Not everyone taking MPA is trying to induce a period. Many prescriptions are written to stop or control abnormal uterine bleeding, sometimes called dysfunctional uterine bleeding, which is heavy, prolonged, or unpredictable bleeding usually caused by anovulatory cycles. In this context, the goal isn’t to make you bleed after you stop the pills; it’s to use the progestin to stabilize the lining while you’re taking it, then allow a controlled, organized shed when you stop.

Research comparing different durations of MPA treatment for this purpose found that longer courses, specifically running the medication for a greater number of cycles rather than a single short course, produced better outcomes in terms of establishing regular cycles and stopping abnormal bleeding. In one comparison, three cycles of treatment was the point at which significant improvement appeared.⁵ This means that if your doctor has you repeating the 10-day course monthly for several months, the early cycles may produce erratic bleeding, but the pattern typically improves with repetition.

Various protocols exist for using progestins in this setting, including higher-dose regimens and combinations of oral pills with an injectable MPA dose for more acute bleeding episodes.⁶ The takeaway is that the post-MPA bleeding timeline can look very different when the medication is being used therapeutically for heavy bleeding versus diagnostically to provoke a period. In the therapeutic scenario, it’s normal for the first couple of withdrawal bleeds to be heavier or come at slightly unpredictable intervals before settling down.

What Happens at the Cellular Level When Things Go Wrong

Some women experience breakthrough bleeding while they’re still taking MPA, rather than waiting for the neat withdrawal bleed after the course ends. This isn’t a sign that the drug “isn’t working.” Research into the molecular effects of MPA on the endometrium has identified a mechanism where progestins can paradoxically trigger a kind of functional hormone withdrawal even while the drug is still present. MPA activates certain signaling pathways that increase production of a protein called FKBP51 in endometrial cells, which in turn blocks both progesterone and cortisol receptors from doing their jobs effectively. The result is that the lining behaves, at a cellular level, as though progesterone support has been pulled even though the drug is circulating.⁷

This mechanism helps explain why some women spot throughout their MPA course, or why breakthrough bleeding is common with long-term progestin-only contraceptive methods. It also explains a frustrating clinical reality: you can’t always predict who will bleed neatly after stopping the pills and who will bleed erratically throughout the course. The molecular response varies from person to person, and there’s no simple blood test to determine your individual sensitivity to this effect beforehand.

Missed Doses and What They Mean for Timing

If you miss one or more doses during your MPA course, the withdrawal timeline becomes less predictable. A skipped pill creates a mini dip in progestin levels, which can cause spotting or light breakthrough bleeding days before you’re “supposed” to bleed. It can also mean that when you do finish the course, your endometrium has already partially shed, so the withdrawal bleed is lighter than expected or arrives earlier. Non-adherence is recognized as a major contributor to unscheduled bleeding with progestin-based regimens in general, and oral MPA is no exception.

The practical advice is straightforward: if you miss a dose, take it as soon as you remember and continue the course. If you miss more than one day, call your prescriber, because the hormonal dip may have already started a partial shed, and trying to “restart” the course from scratch can create confusing bleeding patterns. Consistency matters more with a short 10-to-14-day course than it might with a medication you take indefinitely, because every day represents a larger fraction of the total exposure.

Conditions That Can Delay or Prevent Withdrawal Bleeding

Several underlying conditions can change whether and when you bleed after a course of MPA. The most common categories include situations where estrogen production is significantly reduced, situations where the uterine lining is damaged, and situations where another hormonal imbalance is overriding the normal cycle.

• Low estrogen states: Conditions like hypothalamic amenorrhea (often seen with very low body weight, intense exercise, or severe stress), premature ovarian insufficiency, or certain pituitary disorders can suppress estrogen to the point where the lining never builds up enough to shed. In these cases, no amount of MPA will produce a withdrawal bleed because there’s nothing to withdraw from.
• Uterine scarring: Asherman syndrome, where adhesions form inside the uterus after procedures like a D&C, can physically prevent normal shedding even when the hormonal environment is fine. A negative progestin challenge in a woman with normal estrogen levels raises suspicion for this.
• Thyroid disease and elevated prolactin: Both hypothyroidism and hyperprolactinemia can suppress ovulation and disrupt the normal cycle, but they typically respond to treatment of the underlying condition rather than to progestin courses alone. If your thyroid levels or prolactin are off, fixing those problems often restores cycling without needing repeated MPA courses.
• Polycystic ovary syndrome: Women with PCOS often have adequate or even excess estrogen (because their ovaries produce androgens that get converted to estrogen in fat tissue) but don’t ovulate regularly. These women tend to respond well to MPA withdrawal with a predictable bleed, because the lining is usually thick. Monthly MPA courses are, in fact, one of the standard management strategies for preventing the lining from building up excessively in PCOS.

The point is that a “failed” progestin challenge isn’t always about MPA itself. It’s a signal that something upstream needs investigation.

Oral MPA Versus the Depot Injection

Confusion between oral medroxyprogesterone (the pill you take for 10 to 14 days) and depot medroxyprogesterone acetate (DMPA, the contraceptive shot given every three months) is remarkably common, and the bleeding expectations for the two are completely different. With oral MPA, you expect a withdrawal bleed after the course ends. With the depot injection, the goal is often the opposite: the sustained high progestin levels thin the lining over time, and many women stop having periods altogether after a few injections.

When someone asks “how long after medroxyprogesterone does my period start,” the answer depends entirely on which formulation they’re using. After a short oral course, bleeding typically appears within days. After a depot injection wears off (which can take months, since the drug is designed to release slowly), the return of periods is far more variable. Some women resume cycling within a few weeks of a missed injection; others wait six months or longer. The depot formulation suppresses the entire hormonal axis more deeply, and the time it takes for your own ovulatory function to recover is unpredictable.

Pregnancy as a Reason for No Withdrawal Bleed

It’s worth addressing the elephant in the room. If you were prescribed MPA to induce a period and no bleeding occurs within two weeks of finishing the course, pregnancy should be ruled out before any further diagnostic steps. MPA is not a reliable contraceptive in the short oral-course format, and if you were sexually active during or just before the course, a pregnancy test is the first order of business. Progestins do not reliably prevent implantation or ovulation in a 10-day oral dose, and the drug itself does not harm an early pregnancy, so testing is safe and should not be delayed.

Doctors sometimes forget to mention this, especially if the original reason for the prescription was irregular periods or amenorrhea. But anovulatory women can still ovulate sporadically, and the hormonal changes induced by MPA can occasionally trigger ovulation in the cycle that follows, making pregnancy a realistic possibility in the weeks after a course.

What a “Normal” Post-MPA Bleed Looks Like

Withdrawal bleeding after an oral MPA course is often somewhat different from a typical menstrual period. It tends to be lighter and shorter, especially if your lining was on the thinner side. Some women describe it as more like heavy spotting lasting two to four days rather than a full five-to-seven-day period. The color may be darker or more brownish than the bright red of a heavier flow, reflecting the fact that the shed is more controlled and the volume is smaller.

In contrast, women who had a very thick lining (common in PCOS or prolonged anovulatory cycles) may experience a heavier-than-usual bleed with cramping, because there’s more tissue to shed. If you’ve gone months without a period and then take MPA, that first withdrawal bleed can be surprisingly substantial. This is not a complication; it’s just physics. More lining built up means more lining comes out. If the bleeding soaks through a pad or tampon every hour for more than two hours, or if you feel lightheaded, that warrants a call to your doctor, but moderate-to-heavy flow in this context is expected.

After the withdrawal bleed ends, what happens next depends on why you needed MPA in the first place. If you ovulate on your own in the following cycle, you may have a normal period roughly four to six weeks later. If the underlying problem was anovulation and it hasn’t been addressed, you’ll likely drift back into an irregular pattern and may need another course. Monthly MPA for 10 days each cycle is a common approach for women who need ongoing cycle regulation but aren’t candidates for, or don’t want, hormonal contraceptives.